RLMD
RELMADA THERAPEUTICS, INC.
+0.07 (+1.66%)4.29USD238K成交股數458M市值–本益比(近四季)88.8股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | 1.3M | 1.4M | 1.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 8.4M | 8.1M | 4.0M | 2.8M | 12.0M | 11.0M | 11.1M | 10.7M | 13.3M | 10.5M | 13.7M | 15.9M |
| 銷售管理費用 | 6.6M | 11.4M | 6.3M | 7.4M | 6.3M | 8.1M | 11.9M | 8.1M | 9.7M | 12.2M | 12.3M | 12.3M |
| 營業利益 | −15.0M-18% | −19.5M+2% | −10.3M-55% | −10.2M-46% | −18.2M-21% | −19.1M-16% | −23.0M-12% | −18.8M-33% | −23.0M | −22.7M | −26.0M | −28.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | -1,717.3% | -1,908.9% | -2,331.3% |
| 稅後淨利 | −12.9M-26% | −19.1M-131% | −10.1M-54% | −9.9M-44% | −17.6M-20% | 61.3M-379% | −21.7M-14% | −17.8M-32% | −21.8M | −22.0M | −25.3M | −26.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | -1,665.0% | -1,855.9% | -2,179.6% |
| 稀釋 EPS | -0.11-81% | -0.22-65% | -0.30-58% | -0.30-49% | -0.58-19% | -0.62-15% | -0.72-14% | -0.59-32% | -0.72 | -0.73 | -0.84 | -0.87 |
| 稀釋股數 | 112M | 86.6M | 33.2M | 33.2M | 30.4M | 30.2M | 30.2M | 30.2M | 30.1M | 30.1M | 30.1M | 30.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.3M | 9.8M | 1.4M | 1.4M | 1.1M | 3.9M | 1.5M | 2.1M | 1.3M | 6.7M | 14.5M | 28.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 219M | 235M | 14.9M | 21.1M | 27.7M | 45.8M | 55.7M | 71.0M | 84.4M | 109M | 122M | 136M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 12.5M | 16.6M | 5.4M | 5.2M | 5.2M | 10.3M | 8.1M | – | 12.4M | – | – | 10.1M |
| 股東權益 | 207M | 219M | 9.5M | 15.9M | 22.4M | 35.5M | 47.6M | 61.5M | 72.0M | 101M | 111M | 125M |
| 負債比 | 5.7% | 7.1% | 36.4% | 24.5% | 18.9% | 22.5% | 14.5% | – | 14.6% | – | – | 7.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −15.1M | – | – | −18.1M+39% | – | – | – | −13.0M | – | – | −16.5M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 3.4M | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | 0.00 | –% | -1.45 | – |
| FY2024 | – | – | 0.00 | –% | -2.65 | – |
| FY2023 | 5.2M | +93.7% | 0.00 | 0.0% | -3.28 | – |
| FY2022 | 2.7M | +121.8% | −157M | -5,905.2% | -5.30 | – |
| FY2021 | 1.2M | -14.3% | −126M | -10,487.4% | -7.16 | – |
| FY2020 | 1.4M | +1244.0% | −59.5M | -4,249.2% | -3.81 | −210M |
| FY2019 | 104K | -113.7% | −15.0M | -14,412.6% | -1.62 | −96.9M |
| FY2019 | −761K | – | −17.3M | 2,275.6% | -2.74 | – |